Synergistic Microneedle Systems for Advanced Biological Tissue Interactions
Legal Citation
Summary of the Inventive Concept
The integration of microneedle fabrication technology with AI, IoT, blockchain, and machine learning enables novel biological tissue interactions, such as precise implantation, real-time monitoring, and predictive analytics.
Background and Problem Solved
The original patent on microneedle fabrication and device implantation has limitations in terms of precision, safety, and data management. The new inventive concept addresses these limitations by combining the patented microneedle technology with advanced technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The synergistic microneedle system comprises a microneedle fabricated according to the original patent, integrated with distinct technologies such as AI-powered navigation modules, IoT-enabled sensors, blockchain-based secure databases, and machine learning algorithms. The system enables precise implantation, real-time monitoring, and predictive analytics for biological tissue interactions. For instance, the AI-powered navigation module guides the microneedle through the tissue, while the IoT-enabled sensor detects the outer membrane's thickness. The blockchain-based secure database stores and transmits data from the microneedle, and the machine learning algorithm analyzes the data to predict the success of implantable device implantation.
Novelty and Inventive Step
The new claims introduce novel and non-obvious combinations of the patented microneedle technology with AI, IoT, blockchain, and machine learning. The integration of these technologies enables unprecedented precision, safety, and data management capabilities in biological tissue interactions.
Alternative Embodiments and Variations
Alternative embodiments of the synergistic microneedle system may include variations in the type of AI algorithm used, the specific IoT sensor technology employed, or the blockchain architecture utilized. Additionally, the system could be adapted for use in different biological tissues or applications, such as drug delivery or tissue engineering.
Potential Commercial Applications and Market
The synergistic microneedle system has significant commercial potential in the medical device industry, particularly in the areas of neurosurgery, orthopedics, and cardiology. The system's advanced capabilities in precision, safety, and data management make it an attractive solution for healthcare providers and researchers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B5/685 |
| A | A61 | A61B5/1459 |
| A | A61 | A61B5/1473 |
| A | A61 | A61B5/6868 |
| A | A61 | A61K41/0028 |
| A | A61 | A61N1/0502 |
| A | A61 | A61N1/0529 |
| A | A61 | A61N1/0551 |
| A | A61 | A61N5/0601 |
| B | B21 | B21F45/008 |
| A | A61 | A61B2562/12 |
| A | A61 | A61N2005/0612 |
| A | A61 | A61N2005/0651 |
| B | B23 | B23K1/0008 |
| B | B23 | B23K2101/32 |
Original Patent Information
| Patent Number | US 11,857,343 |
|---|---|
| Title | Microneedle fabrication and device implantation |
| Assignee(s) | The Regents of the University of California |